A home oxygen concentrator that delivers 93% purity at 5 LPM in Mumbai will not deliver 93% purity at 5 LPM in Leh. The pressure swing adsorption (PSA) cycle that produces medical oxygen depends on the partial pressure of oxygen at the inlet, and inlet PO₂ falls with altitude in lockstep with atmospheric pressure. For Indian COPD and LTOT patients living in or travelling to the Himalayan and southern hill stations, the implication is concrete: you may need a higher prescribed flow rate, a larger concentrator class, or a supplemental cylinder to deliver the same alveolar oxygenation that the sea-level prescription assumed.
Why concentrators derate with altitude
A PSA concentrator pulls in room air at ambient pressure, compresses it, and pushes it across a zeolite 13X sieve bed that preferentially adsorbs nitrogen. The remaining gas — enriched in oxygen — is delivered to the patient. The sieve bed’s separation efficiency depends on the partial pressure differential across it. As altitude rises, atmospheric pressure falls, the inlet PO₂ falls, the differential collapses, and the bed delivers less oxygen per cycle.
Atmospheric pressure at sea level is 760 mmHg; at 2000 m it is roughly 596 mmHg; at 3500 m it is roughly 493 mmHg. Inlet PO₂ scales linearly with this. A concentrator that produces 93% purity at 5 LPM at sea level will typically produce 89–91% at 2000 m and 84–87% at 3500 m, with the exact numbers depending on the unit’s compressor headroom, sieve charge, and PSA cycle timing. (ISO 80601-2-69)
The functional equivalent: a 5 LPM concentrator at 3500 m delivers something closer to a 4 LPM sea-level equivalent in terms of oxygen mass per minute reaching the cannula. Most published spec sheets are drawn from sea-level testing and do not state the altitude derating curve.
The clinical compounding — alveolar PAO₂ at altitude
The patient’s own physiology compounds the device derating. Alveolar PAO₂ is the alveolar gas equation working through inspired PO₂, water vapour pressure, and CO₂. At altitude, inspired PO₂ falls; the patient with COPD or ILD already runs a baseline alveolar deficit; the concentrator’s derated output partly fails to plug the gap.
Two specific consequences:
- A patient prescribed 2 LPM at sea level for a target SpO₂ of 90% will desaturate to 84–87% at 2200 m on the same flow setting, even with a concentrator delivering pure 93% gas. The flow needs to step up.
- A patient prescribed 5 LPM at sea level may not reach target saturation at 3500 m on a 5 LPM concentrator at all — the concentrator caps at 5 LPM and the alveolar deficit at altitude outruns the device’s headroom. A 10 LPM unit, or supplemental cylinder oxygen, becomes necessary.
The Indian Chest Society and ICMR have not published an altitude-specific LTOT derating table; the BTS guidance on travel and altitude in chronic respiratory disease is the closest published framework. (British Thoracic Society)
Indian hill stations — altitudes and what they imply
Working list of altitudes for the Indian hill stations where concentrator use is common:
- Leh, Ladakh — ~3500 m. Severe derating territory. Most home concentrators are working at the edge of their compressor envelope. Patients on continuous oxygen need either a 10 LPM unit or cylinder backup or both.
- Tawang — ~3000 m. Similar derating profile.
- Spiti / Kaza — ~3500–4100 m.
- Manali — ~2050 m. Meaningful derating; 5 LPM concentrators still serviceable but at marginal purity for high prescribed flows.
- Shimla — ~2200 m. Same envelope as Manali.
- Mussoorie — ~2000 m.
- Nainital — ~2000 m.
- Darjeeling — ~2000 m.
- Gangtok — ~1600 m. Mild derating, generally manageable with sea-level prescription.
- Srinagar — ~1600 m.
- Ooty — ~2200 m.
- Kodaikanal — ~2100 m.
- Munnar — ~1500 m.
- Coorg — ~1100 m. Borderline; effects measurable but usually not clinically meaningful for low-flow LTOT.
The decision threshold sits around 1500–2000 m. Below 1500 m, sea-level prescriptions usually deliver target saturation. Above 2000 m, every prescription needs review, with explicit field measurement of delivered SpO₂ at the prescribed flow.
What concentrators publish — and don’t — about altitude
Most consumer-grade Indian-market concentrators do not publish an altitude derating curve. The handful that do quote a working ceiling at 2000–2500 m, beyond which the manufacturer makes no purity guarantee:
- Philips EverFlo historically stated a working ceiling around 2400 m on the manufacturer’s spec.
- DeVilbiss 5 LPM historically published a working envelope to ~2500 m.
- Inogen portable units (POCs) — pulse-dose POCs derate sharply with altitude because the dose-trigger and bolus delivery both depend on ambient pressure. Many published curves end at 3000 m.
Indian-market generics from smaller OEMs typically do not publish an altitude curve. In the absence of published data, the prudent assumption is: 2–4 percentage-point purity loss per 1000 m of elevation gain above sea level, with delivered LPM nominally unchanged but oxygen-mass-per-minute reduced proportionally to the purity loss.
Field verification — the only reliable check
Spec sheet derating models are theoretical. The right verification is on-site, with the actual unit, on the actual mains, in the actual installation:
- Oxygen-purity analyser at the concentrator output. Cole-Parmer, Maxtec, or equivalent. A pinch-clamp T-piece on the output line, sampled at the prescribed flow, with a 5-minute warm-up. Read directly.
- Pulse oximeter on the patient at the prescribed flow, after 15 minutes of cannula breathing in steady state. Resting SpO₂ on cannula should reach the prescribed target — typically ≥92% for COPD on LTOT.
- If the analyser reads below 85% at the prescribed flow, the unit is failing in the local altitude/voltage envelope and either flow needs to step up or the unit needs to be sized up.
- If the patient’s SpO₂ on cannula at the prescribed flow falls short of target, flow titration with the prescribing physician is the next step.
Empirically, a 5 LPM unit at 3500 m often reads 84–88% purity at 5 LPM. Stepping flow down to 3 LPM frequently restores purity to ~92% — the bed is given more cycle time per litre delivered. The trade-off is fewer litres per minute. The combination — derated purity at high flow, target purity only at reduced flow — is the central problem of altitude oxygen therapy.
Practical implications for the prescription
For a patient relocating to a hill station, or a patient native to one, the practical step is to upsize the device class:
- Sea-level 2–3 LPM prescription, hill-station altitude 1500–2200 m: stay on a 5 LPM concentrator, retitrate flow on-site, expect to step up to 3–4 LPM to reach target.
- Sea-level 3–4 LPM prescription, hill-station altitude 2000–2500 m: step up to a 10 LPM concentrator. The headroom matters.
- Sea-level 4–5 LPM prescription, altitude 2500 m+: 10 LPM concentrator is mandatory; cylinder backup is necessary; consider whether the geographic relocation is medically advisable at all.
- Any patient at Leh / Spiti / Tawang altitudes (3000+ m): the discussion is no longer about device sizing alone — it is about whether home oxygen at altitude is the right care plan, with hospital-grade concentrators, cylinder logistics, and proximity to a tertiary centre all on the table.
Travelling with a concentrator
Patients travelling temporarily to a hill station — pilgrimages to Vaishno Devi, Amarnath, Manali holidays, Sikkim and Bhutan trips — face a different problem. A portable concentrator (POC) is the typical travel unit. POCs run at lower flow (typically 1–3 LPM continuous-equivalent on pulse dose) and derate harder than stationary units.
For travel above 2000 m the working rules:
- Verify the POC’s manufacturer-published altitude ceiling. Inogen, SimplyGo Mini, and Drive DeVilbiss iGo have published altitude limits.
- Carry a backup small-format cylinder (medical D-size or B-size, regulator with cannula).
- Acclimatise gradually where possible — 1–2 days at intermediate altitude before reaching peak elevation.
- Consult the prescribing physician before the trip on whether altitude exposure is advisable at all for the specific clinical picture (uncontrolled pulmonary hypertension, severe COPD, recent exacerbation are red flags).
Indian Railways permits oxygen concentrators on trains with prior intimation; IndiGo, Air India, and SpiceJet require POC-specific approval and a medical certificate; international carriers each have their own POC list. (DGCA India)
When supplemental cylinder is the right answer
Above ~2500 m, the cylinder is not a backup — it is part of the active therapy. Reasons:
- Concentrators derate; cylinders do not. A medical-oxygen cylinder delivers 99%+ oxygen regardless of ambient pressure.
- Compressor stress at altitude shortens unit life. A concentrator running at the edge of its envelope ages faster.
- Outage handling. Hill-station distribution feeders are often more variable than urban Indian feeders. A cylinder bridges outages without depending on inverter or UPS.
- Cost over a long stay. Cylinder refill economics are often worse at altitude (logistics premium), but a single ‘D’ cylinder at 1500–2000 L medical oxygen content covers 6–10 hours at 4 LPM and is cheap insurance against a derated concentrator.
The hybrid setup — a 10 LPM concentrator for the bulk of therapy plus one or two D-size cylinders for outage and high-flow events — is the standard pattern for serious LTOT at altitude in India.
The takeaway
For LTOT patients above 1500 m in India, sea-level prescriptions don’t translate cleanly. The concentrator derates with altitude; the patient’s alveolar deficit is larger; the prescribed flow needs review on-site. Upsize the device class one step (5 LPM → 10 LPM), verify delivered purity and patient SpO₂ with field instruments, keep cylinder backup for outage and high-flow events. Above 2500 m, treat the cylinder as part of the prescription, not a contingency.
Cross-links
- SpO₂ to flow rate prescription
- GOLD-stage COPD and the LTOT pathway
- Top 5 — 10 LPM oxygen concentrators
- Oxygen concentrator catalogue
- Oxygen cylinder vs concentrator
This guide is editorial opinion and general information. It is not medical advice. Altitude exposure decisions in chronic respiratory disease should be made with your treating physician.